deltatrials
Active Not Recruiting NA INTERVENTIONAL 2-arm NCT03752827

Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears

A Prospective, Double-Blinded, Multi-Center Pivotal Trial of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears

Sponsor: InGeneron, Inc.

Updated 21 times since 2018 Last updated: Aug 15, 2025 Started: May 13, 2019 Primary completion: Nov 30, 2023 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Rotator Cuff Tear and Rotator Cuff Tendinitis, this trial is ongoing. The trial is conducted by InGeneron, Inc. and has accumulated 21 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Dec 2018 – ~Apr 2019 · 4 months · monthly snapshot~Apr 2019 – ~Jun 2019 · 2 months · monthly snapshot~Jun 2019 – ~Sep 2019 · 3 months · monthly snapshot~Sep 2019 – ~Feb 2020 · 5 months · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Sep 2020 · 6 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~May 2021 · 2 months · monthly snapshot~May 2021 – ~Jun 2021 · 31 days · monthly snapshot~Jun 2021 – ~Mar 2022 · 9 months · monthly snapshot~Mar 2022 – ~Jul 2022 · 4 months · monthly snapshot~Jul 2022 – ~Jan 2023 · 6 months · monthly snapshot~Jan 2023 – ~Apr 2023 · 3 months · monthly snapshot~Apr 2023 – ~Oct 2023 · 6 months · monthly snapshot~Oct 2023 – ~Mar 2024 · 5 months · monthly snapshot~Mar 2024 – ~May 2024 · 2 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

21 versions recorded
  1. Sep 2025 — Present [monthly]

    Active Not Recruiting NA

  2. Sep 2024 — Sep 2025 [monthly]

    Active Not Recruiting NA

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  4. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting NA

    Status: CompletedActive Not Recruiting

  5. Mar 2024 — May 2024 [monthly]

    Completed NA

    Status: Active Not RecruitingCompleted

Show 16 earlier versions
  1. Oct 2023 — Mar 2024 [monthly]

    Active Not Recruiting NA

  2. Apr 2023 — Oct 2023 [monthly]

    Active Not Recruiting NA

  3. Jan 2023 — Apr 2023 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  4. Jul 2022 — Jan 2023 [monthly]

    Recruiting NA

  5. Mar 2022 — Jul 2022 [monthly]

    Recruiting NA

  6. Jun 2021 — Mar 2022 [monthly]

    Recruiting NA

  7. May 2021 — Jun 2021 [monthly]

    Recruiting NA

  8. Mar 2021 — May 2021 [monthly]

    Recruiting NA

  9. Jan 2021 — Mar 2021 [monthly]

    Recruiting NA

  10. Sep 2020 — Jan 2021 [monthly]

    Recruiting NA

  11. Mar 2020 — Sep 2020 [monthly]

    Recruiting NA

  12. Feb 2020 — Mar 2020 [monthly]

    Recruiting NA

  13. Sep 2019 — Feb 2020 [monthly]

    Recruiting NA

  14. Jun 2019 — Sep 2019 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  15. Apr 2019 — Jun 2019 [monthly]

    Not Yet Recruiting NA

  16. Dec 2018 — Apr 2019 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • InGeneron, Inc.
Data source: InGeneron, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .